Regeneron Pharmaceuticals Inc – FDA 483, Oct 18, 2019
Regeneron Pharmaceuticals Inc, a biological drug substance manufacturer in Rensselaer, NY, was inspected from October 9-18, 2019. The inspection revealed that the firm's quality control unit failed to fully follow its responsibilities and procedures, specifically by not assessing unexpected events that could affect product safety, purity, or potency for regulatory reporting. This indicates a significant lapse in the firm's quality system regarding deviation management and regulatory compliance.
ID · cdc34046-95b0-4b53-851f-dfbbdefa15ff
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.